Criteria Bio Ventures
Investor profile
Venture capital
Criteria Bio Ventures has backed 2 European tech companies across 2 funding rounds in 2025, joining rounds totalling €61M. Most active in Healthtech. Data as of Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2025
1 yr
Total round €
€61M
sum of rounds joined
Deals by year
distinct rounds / yearCriteria Bio Ventures — deals by year — interactive chart.
Data table
| Criteria Bio Ventures — deals by year | |
|---|---|
| 2025 | 2 |
Top sectors
by dealsCriteria Bio Ventures — top sectors — interactive chart.
Data table
| Criteria Bio Ventures — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsCriteria Bio Ventures — stages — interactive chart.
Data table
| Criteria Bio Ventures — stages | |
|---|---|
| Pre-Seed | 1 |
| Series B | 1 |
Countries
by dealsCriteria Bio Ventures — countries — interactive chart.
Data table
| Criteria Bio Ventures — countries | |
|---|---|
| Spain | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| NRG Therapeutics | UK | 1 | €58M |
| Adaptam Therapeutics | Spain | 1 | €3.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| NRG Therapeutics | Series B | €58M | 2025-09 |
| Adaptam Therapeutics | Pre-Seed | €3.0M | 2025-10 |